Our group studies the PI3K/Akt/mTOR pathway in lung cancer. We have a multi-disciplinary team that incorporates scientists that work on the development and characterization of pathway inhibitors with scientists that develop new mouse models of lung cancer that are driven by altered expression of pathway components. Our scientists work very closely with clinicians who translate successful science into clinical protocols. There are immediate openings in both our drug development areas and in our mouse models projects. Experience with standard techniques used in molecular biology and biochemistry required. Experience with mouse models preferred. Given the highly interactive nature of our group, fluency in spoken and written English is required.

This position is subject to a background investigation.


The NIH is dedicated to building a diverse community in its training and employment programs.

To apply:

The National Cancer Institute coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients. Specifically, the Institute:

• Supports and coordinates research projects conducted by universities, hospitals, research foundations, and businesses throughout this country and abroad through research grants and cooperative agreements.
• Conducts research in its own laboratories and clinics.
• Supports education and training in fundamental sciences and clinical disciplines for participation in basic and clinical research programs and treatment programs relating to cancer through career awards, training grants, and fellowships.
• Supports research projects in cancer control.
• Supports a national network of cancer centers.
• Collaborates with voluntary organizations and other national and foreign institutions engaged in cancer research and training activities.
• Encourages and coordinates cancer research by industrial concerns where such concerns evidence a particular capability for programmatic research.
• Collects and disseminates information on cancer.
• Supports construction of laboratories, clinics, and related facilities necessary for cancer research through the award of construction grants.